Government accords approval to the National Biotechnology Development Strategy
The National
Biotechnology Development Strategy has been approved by the Government of India.
The strategy is an outcome of a two-year-long nationwide consultation process
with multiple stakeholders including concerned ministries, universities, research
institutes, private sector, civil society, consumer groups, non-government and
voluntary organizations and international bodies. The draft strategy, which was
posted on the web, received over 300 comments from all sections of the society.
The strategy has been finalized after careful scrutiny of these.
Announcing
this at a Press Conference today the Union Minister for Science & Technology
and Earth Sciences, Shri. Kapil Sibal said that recognizing that biotechnology
is a sunrise sector which requires focused attention, the Government has accorded
approval for the broad framework of this strategy and the sectors proposed therein.
The strategy, while enabling the full utilization of currently available opportunities
in manufacturing and services, will lay a strong foundation for discovery and
innovation, effectively utilizing novel technology platforms with potential to
contribute to long term benefits in agriculture, animal productivity, human
health, environmental security and sustainable industrial growth.
The Key Elements
of strategy are:
i.
A National Biotechnology Regulatory Authority would be set up as an independent,
autonomous and professionally led body to provide a single window mechanism for
biosafety clearance of genetically modified products and processes.
ii.
A High Powered Inter-ministerial Committee is to be set up under the Chairmanship
of Secretary, DBT, to effectively coordinate the development of the sector by
addressing cross cutting issues
iii.
30% of DBT's Budget is to be Spent on Public-Private Partnership Programmes
·
A Biotechnlogy Industry Partnership Programme (BIPP) for Advanced Technology
would be launched
·
The
existing Small Business Innovation Research Industry (SBIRI) scheme to promote
innovation in SME's has been a success, approval has been accorded for the expansion
of SBIRI during the 11 th Plan.
·
A Biotechnology Industry Research Assistance Council (BIRAC) is to be
launched to act as an interface between academic and private sector, particularly
SMEs and startups; nurture and catalyze R&D and innovation in biotechnology
in the private sector and promote public-private partnerships.
iv.
In
its vision to build world class Human capital, the strategy has focused
on:
·
Improved and expanded PhD and post-doctoral programmes in order to reach the best
levels in the Asian region
·
Enhanced quality of masters level and undergraduate level education
·
Promotion of life sciences and biotechnology at undergraduate and masters levels
·
Creation of a translational workforce of high quality to meet short- and mid-term
requirements of the country
·
Promoting support to institutions for undergraduate education to achieve ' Star
College' status.
v.
A
new role visualized for Autonomous Institutions of DBT to promote excellence in
R&D. Selected institutions will be financially empowered for promoting excellence
in and translational R&D by supporting 'Research Resource Units' in
universities and sister institutions through extramural funding.
vi.
UNESO Regional Centre for Science, Education and Innovation in Biotechnology
being established at Faridabad, Haryana, by DBT as part of a Health Science and
Technology Cluster.
vii.
Innovative
re-entry packages in terms of fellowships and R&D support will be offered
to young and senior scientists of Indian origin to return to Indian laboratories
and pursue research on national priorities.
viii.
In
order to create and strengthen world class institutional research capacity in
biotechnology, 50 Centers of Excellence to be established during the 11 th
plan
ix.
Keeping
in view the requirements for translating scientific leads into useful products
and processes, a new national initiative will be taken up to build capacity in
technology transfer and intellectual property rights.
x.
Cluster development is a key strategy to promote innovation and accelerated
technology and product development. This new approach has been given the green
signal by the Government. Four technology clusters are at an advanced stage of
planning.
xi.
Grand challenges of national relevance in the area of agriculture, health,
energy and environment will be identified through national and international consultations.
Programmes will then be launched through multidisciplinary teams, involving public-private
partnerships.
xii.
DBT's proposal to establish new institutional structures , especially in
areas very vital to India's progress but in which current strengths are suboptimal
has been approved in principle by the Government. The institutions, representing
a new breed, will be designed with a strong bias for integrating science and translation,
and for producing skilled personnel driven towards entrepreneurship.
xiii.
New Legislations:
·
A draft bill entitled 'public Funded R&D (Protection, Utilization and Regulation
of Intellectual Property) Bill, 2007' has been prepared through inter-ministerial
consultation for promotion of innovation, and would be introduced in the Parliament
after obtaining cabinet approval.
·
DNA Profiling Bill to Augment and Transform Forensic Investigation and Criminal
Justice Delivery System to be introduced in the Parliament after obtaining cabinet
approval
xiv.
New Translational Initiatives for Mass Use Technologies- DBT will
give special emphasis on translational initiatives to promote mass use technologies.
xv.
Leveraging International Partnerships to achieve global best practices
in our S&T efforts for joint IP generation, harmonization of regulatory processes,
smooth trans-boundary movement of biological materials, and to access global markets
for our products and processes.
The
details of the strategy are available on Department of Biotechnology's website
http://dbtindia.nic.in.
PRA:LK:13.11.07
(Release ID :32610)